Thalidomide, a drug once used to alleviate morning sickness in pregnant women, exhibits distinct properties due to its ...

Additionally, pharmaceutical companies often study biomarkers during the drug development process. Pathos says that its AI model will enable researchers to discover new biomarkers more efficiently.

Addressing protein aggregation, product stability, supply chains, and regulations requires multiple tools, including ...

An FDA pilot program, known as the Commissioner’s Priority Voucher program, could drastically change the way pharmaceutical ...

Will support spray drying and unit operations including granulation, encapsulation, compression and coating for oral dosage ...

Researchers at the University of Liège (BE) have designed a high-performance, open-access continuous flow process to safely produce key antibacterial drugs from bio-based furfural. The results of ...

On Tuesday, the U.S. Food and Drug Administration announced a new initiative to offer expedited reviews for new medicines, an ...

In the complex and costly world of pharmaceutical development, the process of drug discovery remains one of the most significant bottlenecks, with scientists often describing compound optimization as ...

Both small animal models and microphysiological systems gain in sophistication and value as they expedite in vivo preclinical testing.

SK Biopharmaceuticals signed a memorandum of understanding with PhnyX Lab, a U.S.-based AI startup backed by SK Networks, to ...

The U.S. FDA is launching a program under which its commissioner can issue vouchers to companies he finds are aligned with national priorities to shorten their review time for a drug application to ...

New commissioner Marty Makary says that he wants to speed up the regulatory process and ... the sector to advance drug innovation,” he wrote. But regulation of drug development begins long ...